FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

119361006: Plasma specimen (specimen)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
180900016 Plasma specimen en Synonym Active Entire term case insensitive SNOMED CT core module
707016010 Plasma specimen (specimen) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1220466017 Plasma sample en Synonym Active Entire term case insensitive SNOMED CT core module

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plasma specimen Is a Acellular blood (serum or plasma) specimen true Inferred relationship Existential restriction modifier
Plasma specimen Specimen procedure Hematology false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Plasma true Inferred relationship Existential restriction modifier 1
Plasma specimen Specimen substance Blood false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Liquid substance false Inferred relationship Existential restriction modifier
Plasma specimen Is a Body fluid specimen true Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Blood false Inferred relationship Existential restriction modifier
Plasma specimen Specimen substance Acellular blood false Inferred relationship Existential restriction modifier 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Arbitrary concentration of liver-kidney microsomal 1 antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of beta-aminoisobutyrate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of methadone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of calcitonin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of clobazam in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of alkaline phosphatase bone isoenzyme in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of alkaline phosphatase biliary isoenzyme in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 2,8-dihydroxyadenine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of bicarbonate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of lysine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of protein S in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of alanine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of isovalerylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of dehydroepiandrosterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of N-methyl-D-aspartate receptor antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-hydroxymyristoylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of thyroid stimulating hormone receptor antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of reverse triiodothyronine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of tetracosanoate (C24) in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Catalytic activity of beta-mannosidase in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of adrenocorticotrophic hormone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Titre of antimitochondrial antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of free fatty acids in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of alpha-aminoadipic semialdehyde in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of paraquat in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of serine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of amyloid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of phospholipid antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of cholinesterase in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of teicoplanin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of protein C in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of arachidonic acid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of insulin-like growth factor binding protein 3 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of aldosterone to renin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-hydroxybutyrylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Recumbent arbitrary concentration of aldosterone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of alpha-1 acid glycoprotein in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of total carbamazepine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of sarcosine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of brain natriuretic peptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of midazolam in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of tissue transglutaminase immunoglobulin A antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of coagulation factor VIII in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of thymine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of 17-oxosteroid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass activity of renin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of total porphyrins in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance activity of renin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of methotrexate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of glutamate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of protein C function estimate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of beryllium in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of copper in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Catalytic activity of glutathione peroxidase in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of calcitonin gene-related peptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement 3 breakdown products in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of plasma anion gap (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of tyrosine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of deoxycholic acid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of dabigatran in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of isoniazid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of ethylene glycol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of cystine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of threonine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of parathyroid hormone related peptide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of C reactive protein in plasma by high sensitivity assay (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of ethanol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of cobalt in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of bismuth in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Recumbent catalytic activity of renin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of zonisamide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of neurokinin A in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of venlafaxine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of glycine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of ghrelin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of androstenedione in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of paracetamol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of tetrahydrocortisone in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of cold agglutinin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Catalytic activity of disintegrin and metalloproteinase with thrombospondin type 1 motif 13 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of complement factor B in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of vigabatrin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of dehydroepiandrosterone sulphate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of galactitol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of thyroperoxidase antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of methylmalanoylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of vitamin K1 epoxide in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of vitamin E in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of aquaporin-4 antibody in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Arbitrary concentration of protein S function estimate in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of acylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of 3-hydroxyisovalerylcarnitine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of norclozapine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of desipramine in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of combined total vitamin D2 and D3 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of oestradiol in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of propionic acid in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of voriconazole in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration of somatostatin in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Substance concentration ratio of cholesterol to very low density lipoprotein in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1
Mass concentration of apolipoprotein A2 in plasma (observable entity) Direct site True Plasma specimen Inferred relationship Existential restriction modifier 1

Start Previous Page 5 of 8 Next End

This concept is not in any reference sets

Back to Start